Summary
- Current Price
- As of today, FATE price is $2.65, up +3.52% on
- Current Price All-Time High
- FATE price is currently -97.81% below its historical high of $121.16 set on
- Market Cap
- FATE current market cap is $318M, up +145.08% over the past 365 days
- Revenue
- FATE current annual revenue is $6.65M, down -51.24% year-over-year
- Next Earnings
- The next earnings release for FATE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Fate Therapeutics, Inc. |
| Ticker | NASDAQ: FATE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fatetherapeutics.com |
| Employees | 161 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.65 | ||
| Price, 1D Change | +3.52% | |
| $318M | ||
| - | ||
| - | ||
| 1.93 | ||
| $6.65M | ||
| Revenue, 1Y Change | -51.24% | |
| -$1.15 | ||
| EPS, 1Y Change | +29.96% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.15 | ||
| EPS Estimate | -$0.96 | N/A |
| EPS Est. Change | +16.78% | N/A |
| $6.65M | ||
| Revenue Estimate | $5.51M | N/A |
| Revenue Est. Change | -17.08% | N/A |
| $2.65 | ||
| Price Target | $6.00 | - |
| Price Tgt. Change | +126.42% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.59 | -$1.64 | -2.93% | |
| -$1.14 | -$1.15 | -0.66% | |
| -$0.96 | N/A | +16.78% | |
| -$0.98 | N/A | +14.38% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.60M | $13.63M | +0.22% | |
| $6.46M | $6.65M | +2.85% | |
| $5.51M | N/A | -17.08% | |
| $5.76M | N/A | -13.33% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +134.51% | ||
| -4.68% | ||
| +145.08% | ||
| +15.93% | ||
| -51.24% | ||
| -93.10% | ||
| +29.96% | ||
| +60.56% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.65 | ||
| $1.64 | ||
| $2.51 | ||
| $1.90 | ||
| $2.48 | ||
| $0.01 | ||
| 1.93 | ||
| $0.20 | ||
| 52.49 | ||
| 84.65% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $6.65M | ||
| -$1.15 | ||
| $0.00 | ||
| -94.12% | ||
| -$147.70M | ||
| -2,205.90% | ||
| -$136.32M | ||
| -2,051.08% | ||
| -$134.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.38 | ||
| 5.79 | ||
| 5.79 | ||
| - | ||
| 3 | ||
| -4.36 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 48.92 | ||
| 2.07 | ||
| -1.97 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $207.18M | ||
| $203.66M | ||
| $318.94M | ||
| $208.70M | ||
| $111.75M | ||
| $36.07M | ||
| $77.85M | ||
| $4.56M | ||
| $2.66M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $142.96M | ||
| $141.45M | ||
| $12.90M | ||
| $46.52M | ||
| $12.90M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$106.08M | ||
| $111.17M | ||
| $5.49M | ||
| $5.95M | ||
| -$112.04M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| Wedbush | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Needham | → | |
| Wells Fargo | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
No data
Screeners with FATE
FAQ
- What is the ticker symbol for Fate Therapeutics, Inc.?
- The ticker symbol for Fate Therapeutics, Inc. is NASDAQ:FATE
- Does Fate Therapeutics, Inc. pay dividends?
- No, Fate Therapeutics, Inc. does not pay dividends
- What sector is Fate Therapeutics, Inc. in?
- Fate Therapeutics, Inc. is in the Healthcare sector
- What industry is Fate Therapeutics, Inc. in?
- Fate Therapeutics, Inc. is in the Biotechnology industry
- What country is Fate Therapeutics, Inc. based in?
- Fate Therapeutics, Inc. is headquartered in United States
- When did Fate Therapeutics, Inc. go public?
- Fate Therapeutics, Inc. initial public offering (IPO) was on October 1, 2013
- Is Fate Therapeutics, Inc. in the S&P 500?
- No, Fate Therapeutics, Inc. is not included in the S&P 500 index
- Is Fate Therapeutics, Inc. in the NASDAQ 100?
- No, Fate Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Fate Therapeutics, Inc. in the Dow Jones?
- No, Fate Therapeutics, Inc. is not included in the Dow Jones index
- When was Fate Therapeutics, Inc. last earnings report?
- Fate Therapeutics, Inc.'s most recent earnings report was on August 13, 2026
- When does Fate Therapeutics, Inc. report earnings?
- The next expected earnings date for Fate Therapeutics, Inc. is November 12, 2026
Data Sources & References
- FATE Official Website www.fatetherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434316/000119312526073699/0001193125-26-073699-index.htm
- FATE Profile on Yahoo Finance finance.yahoo.com/quote/FATE
- FATE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fate